Advancing label-free screening technologies to enhance drug discovery efficiency

Area of Science:

• Biochemistry
• Pharmacology
• Drug Discovery

Background:

• Hit identification is crucial but resource-intensive in early drug discovery.
• Traditional assays (fluorescence, luminescence) face limitations like artifacts and reduced biological relevance.
• Growing screening scales necessitate advanced, physiologically relevant strategies.

Purpose of the Study:

• Highlight label-free detection technologies as superior alternatives for hit identification.
• Discuss the principles, applications, and considerations of label-free assays.
• Emphasize the role of label-free approaches in enhancing screening accuracy and accelerating drug discovery.

Main Methods:

• Review of label-free detection technologies for biomolecular interactions and cellular responses.
• Analysis of operating principles, recent applications, and practical considerations.
• Summary of advancements in real-time measurements and throughput.

Main Results:

• Label-free assays enable direct measurement, reducing false positives and improving reliability.
• These methods offer enhanced mechanistic insight and broader target compatibility.
• Recent software innovations facilitate automated kinetic modeling and high-throughput data analysis.

Conclusions:

• Label-free assays are advancing rapidly, offering improved physiological relevance and real-time data.
• Challenges in validating biological relevance and managing kinetic data persist.
• Label-free technologies, supported by software advancements, strengthen screening accuracy and accelerate early drug discovery.